Pacific Biosciences of California, Inc. (FRA:P09)

Market Cap	574.30M +15.1%
Revenue (ttm)	131.75M -10.7%
Net Income	-429.25M
EPS	-1.45
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,888
Average Volume	1,348
Open	2.105
Previous Close	2.147
Day's Range	2.021 - 2.203
52-Week Range	0.780 - 2.300
Beta	n/a
RSI	51.12
Earnings Date	Feb 12, 2026

About FRA:P09

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified ...

• Industry: Laboratory Analytical Instruments
• Founded: 2000
• Employees: 575
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: P09

Financial Performance

In 2024, FRA:P09's revenue was $154.01 million, a decrease of -23.19% compared to the previous year's $200.52 million. Losses were -$309.85 million, 1.02% more than in 2023.

Financial numbers in USD